A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Acular Indications, Dosage, Storage, Stability - Ketorolac tromethamine
Acular Indications, Dosage, Storage, Stability - Ketorolac tromethamine
INDICATIONS AND USAGE
ACULAR® ophthalmic solution is indicated for
the temporary relief of ocular itching due to seasonal allergic conjunctivitis.
ACULAR® ophthalmic solution is also indicated for the treatment
of postoperative inflammation in patients who have undergone cataract extraction.
DOSAGE AND ADMINISTRATION
The recommended dose of ACULAR® ophthalmic solution
is one drop (0.25 mg) four times a day for relief of ocular itching due to seasonal
allergic conjunctivitis.
For the treatment of postoperative inflammation in patients
who have undergone cataract extraction, one drop of ACULAR® ophthalmic
solution should be applied to the affected eye(s) four times daily beginning
24 hours after cataract surgery and continuing through the first 2 weeks of
the postoperative period. ACULAR® ophthalmic solution has been
safely administered in conjunction with other ophthalmic medications such as
antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and
mydriatics.
HOW SUPPLIED
ACULAR® (ketorolac tromethamine ophthalmic solution)
is supplied sterile in opaque white LDPE plastic bottles with white droppers
with gray high impact polystyrene (HIPS) caps as follows: 3 mL in 6 mL bottle
NDC 0023-2181-03, 5 mL in 10 mL bottle NDC 0023-2181-05, 10 mL
in 10 mL bottle NDC 0023-2181-10.
Store at room temperature 15°C – 30°C (59°F- 86°F) with protection
from light.
Rx only
U.S. Pat.: 4,454,151; 5,110,493; and 5,414,011
©2002 Allergan, Irvine, CA 92612, U.S.A.
Revised February 2002
ACULAR, a registered trademark of SYNTEX (U.S.A.)
L.L.C., is manufactured and distributed by Allergan, Inc., under license from
its developer, SYNTEX (U.S.A.) L.L.C., Palo Alto, CA, U.S.A. 8344X
top
